PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
20575623-0	2010	Repurposing an old drug to improve the use and safety of tissue plasminogen activator for acute ischemic stroke: minocycline.	Minocycline	113-124	chromosome 20 open reading frame 181	Homo sapiens	57-85	
23691430-2	2013	The tetracycline antibiotic minocycline inhibits matrix MMPs and reduces macroscopic HT in rodents with stroke treated with tissue plasminogen activator (tPA).	Minocycline	28-39	chromosome 20 open reading frame 181	Homo sapiens	124-152	
23691430-2	2013	The tetracycline antibiotic minocycline inhibits matrix MMPs and reduces macroscopic HT in rodents with stroke treated with tissue plasminogen activator (tPA).	Minocycline	28-39	chromosome 20 open reading frame 181	Homo sapiens	154-157	
23691430-4	2013	The WAIMATSS is a multicentre, prospective, and randomised pilot study of intravenous minocycline, 200 mg 12 hourly for 5 doses, compared with standard care, in patients with ischaemic stroke treated with intravenous tPA.	Minocycline	86-97	chromosome 20 open reading frame 181	Homo sapiens	217-220	
20410869-0	2010	Repurposing an old drug to improve the use and safety of tissue plasminogen activator for acute ischemic stroke: minocycline.	Minocycline	113-124	chromosome 20 open reading frame 181	Homo sapiens	57-85